VASCULAR DISEASES
Clinical trials for VASCULAR DISEASES explained in plain language.
Never miss a new study
Get alerted when new VASCULAR DISEASES trials appear
Sign up with your email to follow new studies for VASCULAR DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Anti-Aging supplement TA-65 targets blood vessel decline in new trial
Disease control Not yet recruitingThis study tests whether TA-65, a dietary supplement that activates telomerase, can improve small blood vessel function in healthy older adults and people with coronary artery disease. Researchers will measure blood vessel responses in the skin and track blood pressure. The trial…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New laser study aims to clear red skin conditions
Disease control Not yet recruitingThis study will test a special laser (Vbeam Pro) to see if it can safely clear up red skin conditions like rosacea and port-wine stain birthmarks. About 40 adults will receive the laser treatment and be checked for improvement. The goal is to reduce the appearance of these vascul…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: Candela Corporation • Aim: Disease control
Last updated May 17, 2026 01:58 UTC
-
Dissolving magnesium stent could change heart disease treatment
Disease control Not yet recruitingThis study tests a new type of heart stent made from magnesium that slowly dissolves over time. It is designed to open blocked arteries in people with coronary artery disease. About 1,859 participants will receive either the dissolving stent or a standard permanent stent. The goa…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: Teleflex • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New device zaps lung arteries to ease heart failure
Disease control Not yet recruitingThis study tests a device that uses radiofrequency energy to treat high blood pressure in the lungs of people with heart failure. The treatment aims to reduce serious heart events like hospitalizations or death. About 750 adults with stable heart failure will be randomly assigned…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: Pulnovo Medical, Inc. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC